nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—SIK1—mouth—periodontitis	0.0267	0.146	CbGeAlD
Dabrafenib—SIK1—trigeminal ganglion—periodontitis	0.0197	0.108	CbGeAlD
Dabrafenib—SIK1—parotid gland—periodontitis	0.0186	0.102	CbGeAlD
Dabrafenib—RAF1—neck—periodontitis	0.0182	0.0994	CbGeAlD
Dabrafenib—SIK1—connective tissue—periodontitis	0.0164	0.0895	CbGeAlD
Dabrafenib—RAF1—trigeminal ganglion—periodontitis	0.0157	0.0858	CbGeAlD
Dabrafenib—RAF1—parotid gland—periodontitis	0.0148	0.0809	CbGeAlD
Dabrafenib—RAF1—connective tissue—periodontitis	0.013	0.0712	CbGeAlD
Dabrafenib—RAF1—epithelium—periodontitis	0.0124	0.0676	CbGeAlD
Dabrafenib—SLC22A8—trigeminal ganglion—periodontitis	0.00912	0.0499	CbGeAlD
Dabrafenib—ABCG2—trigeminal ganglion—periodontitis	0.00649	0.0355	CbGeAlD
Dabrafenib—ABCG2—parotid gland—periodontitis	0.00612	0.0335	CbGeAlD
Dabrafenib—ABCB1—trigeminal ganglion—periodontitis	0.0032	0.0175	CbGeAlD
Dabrafenib—ABCB1—epithelium—periodontitis	0.00252	0.0138	CbGeAlD
Dabrafenib—RAF1—Signaling by Interleukins—IL1B—periodontitis	0.00118	0.00144	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SLC52A3—periodontitis	0.00117	0.00143	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD14—periodontitis	0.00116	0.00142	CbGpPWpGaD
Dabrafenib—BRAF—Disease—LTF—periodontitis	0.00115	0.0014	CbGpPWpGaD
Dabrafenib—RAF1—SHP2 signaling—IL6—periodontitis	0.00113	0.00139	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—FGF2—periodontitis	0.00113	0.00139	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—MET—periodontitis	0.00113	0.00138	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—VCAM1—periodontitis	0.00112	0.00138	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—periodontitis	0.00112	0.00137	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—FGF2—periodontitis	0.00109	0.00133	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—FGF2—periodontitis	0.00109	0.00133	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—FGF2—periodontitis	0.00107	0.00131	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—FGF2—periodontitis	0.00106	0.0013	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—TGFB1—periodontitis	0.00106	0.0013	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1A—periodontitis	0.00105	0.00129	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL18—periodontitis	0.00105	0.00129	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL3—periodontitis	0.00105	0.00128	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—periodontitis	0.00105	0.00128	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—TGFB1—periodontitis	0.00104	0.00127	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—FGF2—periodontitis	0.00102	0.00125	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—IL6—periodontitis	0.00102	0.00125	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—GGT1—periodontitis	0.00102	0.00124	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—FGF2—periodontitis	0.00102	0.00124	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—FGF2—periodontitis	0.00101	0.00124	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00101	0.00124	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—FGF2—periodontitis	0.00101	0.00123	CbGpPWpGaD
Dabrafenib—RAF1—NCAM signaling for neurite out-growth—IL6—periodontitis	0.000999	0.00122	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1A—periodontitis	0.000996	0.00122	CbGpPWpGaD
Dabrafenib—BRAF—Disease—ACP5—periodontitis	0.000995	0.00122	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL18—periodontitis	0.000994	0.00122	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CIITA—periodontitis	0.000984	0.0012	CbGpPWpGaD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—TNF—periodontitis	0.000972	0.00119	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—AGER—periodontitis	0.000955	0.00117	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—MMP9—periodontitis	0.000952	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—FCGR2A—periodontitis	0.000952	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FGF2—periodontitis	0.000946	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—FGF2—periodontitis	0.000946	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—FGF2—periodontitis	0.000946	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—FGF2—periodontitis	0.000937	0.00115	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—TGFB1—periodontitis	0.000937	0.00115	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—FGF2—periodontitis	0.000931	0.00114	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TGFB1—periodontitis	0.000929	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—FGF2—periodontitis	0.000929	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—FGF2—periodontitis	0.000925	0.00113	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—SLC52A3—periodontitis	0.000922	0.00113	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—MMP9—periodontitis	0.000898	0.0011	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL3—periodontitis	0.000896	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TIMP1—periodontitis	0.000893	0.00109	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.00089	0.00109	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TNF—periodontitis	0.000868	0.00106	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CTSC—periodontitis	0.00086	0.00105	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—SLC52A3—periodontitis	0.000853	0.00104	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGF2—periodontitis	0.000838	0.00103	CbGpPWpGaD
Dabrafenib—RAF1—IRS-mediated signalling—IL6—periodontitis	0.000836	0.00102	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CRP—periodontitis	0.000832	0.00102	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—IL6—periodontitis	0.000828	0.00101	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—IL1B—periodontitis	0.000828	0.00101	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CCR2—periodontitis	0.000825	0.00101	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—LBP—periodontitis	0.000815	0.000998	CbGpPWpGaD
Dabrafenib—RAF1—IRS-related events—IL6—periodontitis	0.000813	0.000995	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ACP5—periodontitis	0.000808	0.000989	CbGpPWpGaD
Dabrafenib—RAF1—IRS-related events triggered by IGF1R—IL6—periodontitis	0.000806	0.000986	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000803	0.000982	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IFNG—periodontitis	0.0008	0.000979	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—IL6—periodontitis	0.000798	0.000977	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—TLR4—periodontitis	0.000798	0.000977	CbGpPWpGaD
Dabrafenib—RAF1—Disease—LTF—periodontitis	0.000794	0.000972	CbGpPWpGaD
Dabrafenib—RAF1—IGF1R signaling cascade—IL6—periodontitis	0.000784	0.00096	CbGpPWpGaD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—IL6—periodontitis	0.000784	0.00096	CbGpPWpGaD
Dabrafenib—RAF1—Insulin receptor signalling cascade—IL6—periodontitis	0.000784	0.00096	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—TGFB1—periodontitis	0.000784	0.00096	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—TGFB1—periodontitis	0.00078	0.000954	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.000768	0.00094	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—TLR2—periodontitis	0.000767	0.000939	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—VIP—periodontitis	0.000759	0.000929	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—CXCL8—periodontitis	0.000744	0.00091	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MET—periodontitis	0.000736	0.000901	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—TNF—periodontitis	0.000732	0.000896	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FCGR3A—periodontitis	0.000727	0.000889	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000723	0.000884	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—IL6—periodontitis	0.000721	0.000882	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL1B—periodontitis	0.000714	0.000873	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—IL6—periodontitis	0.000706	0.000864	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—IL6—periodontitis	0.000695	0.000851	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD79A—periodontitis	0.000693	0.000848	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CD14—periodontitis	0.000691	0.000846	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—IL6—periodontitis	0.00069	0.000844	CbGpPWpGaD
Dabrafenib—RAF1—Disease—ACP5—periodontitis	0.000689	0.000843	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—PPARA—periodontitis	0.000687	0.000841	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000678	0.00083	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCR2—periodontitis	0.000676	0.000828	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—IL6—periodontitis	0.000672	0.000822	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—IL6—periodontitis	0.000656	0.000803	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Insulin receptor—IL6—periodontitis	0.000652	0.000798	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—VIP—periodontitis	0.000648	0.000793	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—FGF2—periodontitis	0.000644	0.000788	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TGFB1—periodontitis	0.000643	0.000787	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—VCAM1—periodontitis	0.000641	0.000784	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL3—periodontitis	0.00062	0.000759	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—FGF2—periodontitis	0.000619	0.000757	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IFNG—periodontitis	0.000617	0.000754	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MMP2—periodontitis	0.000614	0.000751	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—PPARA—periodontitis	0.000608	0.000744	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TNF—periodontitis	0.0006	0.000735	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	0.000595	0.000728	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—IL6—periodontitis	0.000591	0.000723	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IFNG—periodontitis	0.000582	0.000712	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.00058	0.00071	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCR2—periodontitis	0.000577	0.000707	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—PPARA—periodontitis	0.000577	0.000706	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—AGER—periodontitis	0.000567	0.000694	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—IL6—periodontitis	0.000557	0.000682	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—MMP1—periodontitis	0.000555	0.00068	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TGFB1—periodontitis	0.000555	0.000679	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FCGR2A—periodontitis	0.000554	0.000678	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1B—periodontitis	0.00055	0.000673	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—GGT1—periodontitis	0.000545	0.000667	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ACP5—periodontitis	0.000543	0.000665	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000542	0.000663	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—IL6—periodontitis	0.000533	0.000653	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SLC52A3—periodontitis	0.00053	0.000648	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCR2—periodontitis	0.000526	0.000644	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MET—periodontitis	0.000525	0.000643	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—IL6—periodontitis	0.000525	0.000642	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—ADRB1—periodontitis	0.000524	0.000641	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—IL6—periodontitis	0.000522	0.000639	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1B—periodontitis	0.000519	0.000635	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TNF—periodontitis	0.000518	0.000634	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—periodontitis	0.000516	0.000632	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—PPARA—periodontitis	0.000508	0.000621	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ACP5—periodontitis	0.000503	0.000616	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—IL6—periodontitis	0.000501	0.000614	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—NOS2—periodontitis	0.000501	0.000613	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—IL6—periodontitis	0.000499	0.000611	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—IL6—periodontitis	0.000496	0.000608	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CRP—periodontitis	0.000494	0.000605	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—IL6—periodontitis	0.000494	0.000605	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—PPARA—periodontitis	0.00049	0.0006	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000486	0.000594	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CCR2—periodontitis	0.000481	0.000588	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1RN—periodontitis	0.000478	0.000586	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—TLR4—periodontitis	0.000474	0.00058	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.00047	0.000575	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—IL6—periodontitis	0.000465	0.000569	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—IL6—periodontitis	0.000465	0.000569	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	0.000465	0.000569	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—PPARA—periodontitis	0.000462	0.000565	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SLC52A3—periodontitis	0.000461	0.000565	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MMP9—periodontitis	0.000461	0.000565	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—IL6—periodontitis	0.000461	0.000564	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—IL6—periodontitis	0.000458	0.00056	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—IL6—periodontitis	0.000457	0.000559	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—IL6—periodontitis	0.000455	0.000556	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GGT1—periodontitis	0.00045	0.00055	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCR2—periodontitis	0.000449	0.00055	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—VIP—periodontitis	0.000448	0.000549	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ADRB1—periodontitis	0.000447	0.000547	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TLR2—periodontitis	0.000447	0.000547	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MMP2—periodontitis	0.000438	0.000536	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—PPARA—periodontitis	0.000428	0.000523	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD79A—periodontitis	0.00042	0.000514	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.00042	0.000514	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—FGF2—periodontitis	0.000416	0.000509	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	0.000412	0.000504	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD14—periodontitis	0.000403	0.000493	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCR2—periodontitis	0.0004	0.000489	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—MMP3—periodontitis	0.000399	0.000488	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000398	0.000487	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00039	0.000477	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—VCAM1—periodontitis	0.000389	0.000476	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000379	0.000463	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—FGF2—periodontitis	0.000367	0.00045	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NTRK1—periodontitis	0.000366	0.000448	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—FGF2—periodontitis	0.000353	0.000432	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NOS2—periodontitis	0.00035	0.000429	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1A—periodontitis	0.000344	0.000421	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL18—periodontitis	0.000344	0.000421	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP3—periodontitis	0.00034	0.000417	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—AGER—periodontitis	0.00033	0.000404	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MMP9—periodontitis	0.000329	0.000403	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL6—periodontitis	0.000322	0.000394	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PPARA—periodontitis	0.000322	0.000394	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—IL6—periodontitis	0.000317	0.000387	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000316	0.000386	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ACP5—periodontitis	0.000312	0.000382	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCR2—periodontitis	0.000311	0.00038	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ADRB1—periodontitis	0.000309	0.000379	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL6—periodontitis	0.000304	0.000372	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GGT1—periodontitis	0.000302	0.00037	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CRP—periodontitis	0.000288	0.000352	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—IL6—periodontitis	0.000287	0.000351	CbGpPWpGaD
Dabrafenib—BRAF—Disease—FGF2—periodontitis	0.000286	0.00035	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000284	0.000348	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GGT1—periodontitis	0.00028	0.000342	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000279	0.000341	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TLR4—periodontitis	0.000276	0.000338	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000274	0.000335	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ACP5—periodontitis	0.000272	0.000333	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—periodontitis	0.000271	0.000332	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—periodontitis	0.000266	0.000326	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCL2—periodontitis	0.000259	0.000317	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—periodontitis	0.000258	0.000315	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000256	0.000313	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TNF—periodontitis	0.000253	0.00031	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NTRK1—periodontitis	0.000253	0.00031	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NOS2—periodontitis	0.000242	0.000297	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP3—periodontitis	0.000235	0.000288	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	0.000231	0.000283	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL2—periodontitis	0.000221	0.000271	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARA—periodontitis	0.000216	0.000265	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FGF2—periodontitis	0.000214	0.000262	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—periodontitis	0.000209	0.000256	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL8—periodontitis	0.000205	0.000251	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—IL6—periodontitis	0.000204	0.00025	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IFNG—periodontitis	0.000201	0.000246	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARA—periodontitis	0.0002	0.000245	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—FGF2—periodontitis	0.0002	0.000245	CbGpPWpGaD
Dabrafenib—RAF1—Disease—FGF2—periodontitis	0.000198	0.000242	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—periodontitis	0.000186	0.000228	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000181	0.000222	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—IL6—periodontitis	0.000181	0.000221	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—periodontitis	0.00018	0.00022	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—periodontitis	0.000178	0.000218	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL8—periodontitis	0.000175	0.000214	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GGT1—periodontitis	0.000174	0.000212	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ACP5—periodontitis	0.000168	0.000205	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP9—periodontitis	0.000158	0.000194	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL2—periodontitis	0.000153	0.000187	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GGT1—periodontitis	0.000151	0.000185	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—periodontitis	0.000141	0.000172	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6—periodontitis	0.00014	0.000172	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FGF2—periodontitis	0.000138	0.000169	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—periodontitis	0.00013	0.00016	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—periodontitis	0.00013	0.000159	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—periodontitis	0.000129	0.000158	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARA—periodontitis	0.000124	0.000152	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL8—periodontitis	0.000121	0.000148	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6—periodontitis	0.000115	0.000141	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP9—periodontitis	0.000109	0.000134	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARA—periodontitis	0.000108	0.000132	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6—periodontitis	0.000105	0.000129	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6—periodontitis	9.83e-05	0.00012	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6—periodontitis	9.71e-05	0.000119	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GGT1—periodontitis	9.32e-05	0.000114	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—periodontitis	9.02e-05	0.00011	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—periodontitis	8.08e-05	9.89e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—periodontitis	7.04e-05	8.61e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6—periodontitis	6.8e-05	8.32e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARA—periodontitis	6.67e-05	8.16e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—periodontitis	4.34e-05	5.31e-05	CbGpPWpGaD
